Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group-Reference-Cited by-同舟云学术

Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group

Published:2013-12 Issue:12 Volume:24 Page:3051-3055
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Giessen C.,Graeven U.,Laubender R.P.,Modest D.P.,Schulz C.,Porschen R.,Schmiegel W.,Reinacher-Schick A.,Hegewisch-Becker S.,Stintzing S.,Heinemann V.

Funder

Roche and Sanofi-Aventis

Merck Serono, Roche, and Pfizer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/12/3051/16702308/mdt402.pdf

Reference19 articles.

1. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials;Schulz;BMJ,2010

2. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial;Adams;Lancet Oncol,2011

3. XELOX versus FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results;Cassidy;Br J Cancer,2011

4. Randomised phase-II trial of CAPIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer;Souglakos;Br J Cancer,2012

5. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients;Köhne;Ann Oncol,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker-stratified first-line treatment of right-sided metastatic colon cancer with interdisciplinary collaboration in the IVOPAK II trial;Anti-Cancer Drugs;2024-08-07

2. Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice;JNCI: Journal of the National Cancer Institute;2023-05-17

3. Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018;Frontiers in Pharmacology;2022-10-19

4. Comments on the CAIRO4 Trial Secondary Outcomes Report—Reply;JAMA Surgery;2022-06-01

5. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment;JAMA Surgery;2021-12-01